Epilepsy, a chronic neurological disorder characterized by recurrent seizures, affects around 50 million people worldwide. Despite the availability of numerous antiepileptic drugs (AEDs), around one-third of patients continue to experience seizures. This necessitates continuous research and development in this field. This article aims to provide an overview of the recent advancements in epilepsy management.
Several new AEDs have been introduced in recent years, including brivaracetam, cenobamate, and perampanel. These drugs, with their unique mechanisms of action, offer improved seizure control, fewer side effects, and better patient compliance compared to traditional AEDs. They can be used alone or in combination with other drugs, providing new therapeutic options for patients with drug-resistant epilepsy.
Surgical intervention is considered for patients who do not respond to medical therapy. Recent advancements in neuroimaging and surgical techniques, such as stereotactic laser ablation and responsive neurostimulation, have improved the precision and safety of epilepsy surgery. These minimally invasive procedures offer promising outcomes with reduced postoperative complications.
Genetic testing has become increasingly important in the diagnosis and management of epilepsy. Identification of specific genetic mutations can help in predicting disease prognosis, guiding treatment decisions, and providing genetic counseling. Moreover, ongoing research in gene therapy holds the potential for a cure in certain genetic forms of epilepsy.
The COVID-19 pandemic has accelerated the adoption of telemedicine in epilepsy care. Virtual visits, remote monitoring of seizures, and digital cognitive assessments have proven effective in providing continuous care to patients, reducing the need for hospital visits, and improving patient satisfaction.
Recent advances in epilepsy management have significantly improved the quality of life for patients. Continuous research and innovation in this field hold the promise of further advancements, potentially leading to more effective treatments and even a cure for this debilitating condition.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation